Enhanced Nano-Vaccine Utilizing Biomineralized Virus-Like Particles for Efficient Glioblastoma Immunotherapy via the Nose-to-Brain Delivery Pathway

Researchers developed a calcium phosphate (CaP)-covered nanovaccine (NV) based on hepatitis B core antigen derived virus-like particles (HBc VLPs), optimized for mucosal delivery applications.